US · Healthcare

Eagle Pharmaceuticals Inc (EGRX)

Drug Manufacturers - Specialty & Generic

Eagle Pharmaceuticals Inc (EGRX) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for EGRX

P/E ratio

18.00

Eagle Pharmaceuticals Inc (EGRX) — FAQ

What is EGRX's P/E ratio?

The price-to-earnings (P/E) ratio for Eagle Pharmaceuticals Inc (EGRX) is 18.00 (data as of 2026-03-24).

Does Eagle Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Eagle Pharmaceuticals Inc (EGRX). Check the MyAverix Finance app for the latest dividend data.

What sector is Eagle Pharmaceuticals Inc in?

Eagle Pharmaceuticals Inc (EGRX) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is EGRX listed on?

EGRX is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)